Funding for this research was provided by:
NIH Office of the Director (DP5OD024579)
National Human Genome Research Institute (T32HG002536)
National Institutes of Health-National Cancer Institute (T32LM012424)
Article History
Received: 15 August 2021
Accepted: 22 August 2022
First Online: 5 September 2022
Declarations
:
: Written consent was obtained for use of biopsy samples from Arboleda-Tham syndrome patients. The data used in this study was approved by the UCLA Institutional Review Board, study number IRB#11-001087.
: Not applicable.
: The authors declare no competing interests.